Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Dr.Stine Ankerstjerne ApS
APS
Active
CVR 45379248
Th. Bergs Gade 12
Wholesale of perfume and cosmetics · NACE 4645
Est. 2025
6 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 1,9M
EBITDA margin
54.0%
Equity ratio
48.4%
Financial strength
Net profit 2025
DKK 798K
6 employees
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
1M
2025
Key figures
Annual report 2025
Revenue
DKK 1,9M
—
EBITDA
DKK 1M
—
Net profit
DKK 798K
—
Total assets
DKK 1,7M
—
Equity
DKK 838K
—
Employees
6
—
Company information
Legal name
Dr.Stine Ankerstjerne ApS
CVR number
45379248
Legal form
Anpartsselskab
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
1. februar 2025
Share capital
DKK 40.000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller bestyrelsesformanden.
Company purpose
Selskabets formål er at drive virksomhed med udvikling og salg af skincareprodukter, og anden hermed forbundet virksomhed.
Contact
Address
Th. Bergs Gade 12
Phone
+4596211506
Email
stine@ankerstjerne.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of perfume and cosmetics
Companies in Frederikshavn
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
2M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2025
Income statement
DKK thousands
Item
2025
Revenue
1.908
Staff expenses
-878
EBITDA
1.030
Depreciation & amort.
-0
EBIT
1.030
Net financials
-7
Profit before tax
1.024
Tax
226
Net profit
798
Balance sheet
DKK thousands
Item
2025
Total assets
1.732
Equity
838
Long-term debt
0
Short-term debt
894
Total debt
894
Financial ratios
5-year trend
EBITDA margin
54.0%
This company
15.8%
Market median
+242% vs market
2025
2025
Equity ratio
48.4%
This company
38.2%
Market median
+27% vs market
2025
2025
Return on equity
95.2%
This company
18.4%
Market median
+417% vs market
2025
2025
Net profit margin
41.8%
This company
8.1%
Market median
+416% vs market
2025
2025
Asset turnover
1.10×
This company
1.12×
Market median
+2% vs market
2025
2025
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-02-01 – 2025-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
SL
Stine Lysgaard Ankerstjerne
Chief Executive Officer
Chief Executive Officer
2025
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
OA
Odd Andre Wathne Ankerstjerne
Chairman
2025
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Dr.Ankerstjerne AS
Individual
100.0%
100.0%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Dr.Stine Ankerstjerne ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Stine Lysgaard Ankerstjerne
Chief Executive Officer
0 companies
Odd Andre Wathne Ankerstjerne
Chairman
0 companies